%20(2).png){kind=logo}
10 years ago, Christophe Weber became the first non-Japanese CEO in Takeda Pharmaceuticals’ 242 year history.
What role does serendipity play in forming a multi-billion dollar targeted oncology company?
Jazz Pharma's journey of improvisation to innovation
.jpg)
Jazz, a T50 Pharma, and unicorn among unicorns, thrives on a people-first culture. CEO Bruce Cozadd's mission-driven approach led to 11 therapeutics in 20 years.
In its fifth year, the 40 Under 40 program celebrates the industry’s most highly regarded young talent.
Startups have struggled in digital health but LLMs have the potential to unlock growth and disruption.
.jpg)
.svg)